Literature DB >> 26645385

Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.

Rosa R Cui1, Jason D Wright.   

Abstract

Symptomatic fibroids are a common indication for hysterectomy or myomectomy. Although rare, unexpected gynecologic malignancies in presumed fibroids have been documented. In cases where tissue retrieval is performed through morcellation, there is increasing concern that intra-abdominal dispersion of occult uterine malignancies may lead to peritoneal dissemination and worse outcomes. We examined the available literature to determine the prevalence of all uterine cancers in women undergoing hysterectomy or myomectomy for benign uterine disease, with attention to the risk of morcellating occult uterine sarcomas. We also reviewed the available tools for preoperative discrimination between benign and malignant uterine disease.

Entities:  

Mesh:

Year:  2016        PMID: 26645385     DOI: 10.1097/GRF.0000000000000163

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  7 in total

1.  Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.

Authors:  Francesco Multinu; Jvan Casarin; Lucia Tortorella; Yajue Huang; Amy Weaver; Stefano Angioni; Gian Benedetto Melis; Andrea Mariani; Elizabeth A Stewart; Shannon K Laughlin-Tommaso
Journal:  Am J Obstet Gynecol       Date:  2018-11-14       Impact factor: 8.661

Review 2.  Myomas and Adenomyosis: Impact on Reproductive Outcome.

Authors:  Nikos F Vlahos; Theodoros D Theodoridis; George A Partsinevelos
Journal:  Biomed Res Int       Date:  2017-11-06       Impact factor: 3.411

3.  Incidental leiomyosarcoma found at the time of cesarean hysterectomy for morbidly adherent placenta.

Authors:  Lauren C Hand; Alexis C Gimovsky; Joanna S Y Chan; Norman G Rosenblum; Christine H Kim
Journal:  Gynecol Oncol Rep       Date:  2017-04-29

Review 4.  The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium.

Authors:  Piotr Rubisz; Michał Ciebiera; Lidia Hirnle; Magdalena Zgliczyńska; Tomasz Łoziński; Piotr Dzięgiel; Christopher Kobierzycki
Journal:  Int J Mol Sci       Date:  2019-03-06       Impact factor: 5.923

Review 5.  Outcome and Management of Uterine Leiomyosarcoma Treated Following Surgery for Presumed Benign Disease: Review of Literature.

Authors:  Tanitra Tantitamit; Kuan-Gen Huang; Manatsawee Manopunya; Chih-Feng Yen
Journal:  Gynecol Minim Invasive Ther       Date:  2018-05-02

6.  Increased LDH5/LDH1 ratio in preoperative diagnosis of uterine sarcoma with inconclusive MRI and LDH total activity but suggestive CT scan: a case report.

Authors:  Antonio Mollo; Antonio Raffone; Antonio Travaglino; Annalisa Di Cello; Gabriele Saccone; Fulvio Zullo; Giuseppe De Placido
Journal:  BMC Womens Health       Date:  2018-10-19       Impact factor: 2.809

7.  Preoperative Blood Inflammatory Markers for the Differentiation of Uterine Leiomyosarcoma from Leiomyoma.

Authors:  Dong Soo Suh; Yong Jung Song; Hyun-Jin Roh; Sang Hun Lee; Dae Hoon Jeong; Tae Hwa Lee; Kyung Un Choi; Ki Hyung Kim
Journal:  Cancer Manag Res       Date:  2021-06-24       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.